Close Menu

NEW YORK (GenomeWeb) – Precipio said after the close of the market on Monday that its third quarter net sales fell 26 percent year over year.

For the three months ended Sept. 30, the firm posted net sales of $270,000, compared to $365,000 in Q3 2016. Precipio attributed the drop to a 23 percent year-over-year decrease in cases processed in the recently completed quarter. In Q3 2017, 207 cases were processed, down from 269 cases a year ago, the firm said, adding that the downtick resulted from turnover in key sales personnel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.